Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 7/20 | 0.59 |
| ▸ | ADA | P00813 | 1/20 | 0.55 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | PI4KA | P42356 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | ADCY1 | Q08828 | 1/20 | 0.54 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.54 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.54 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5962598 | 1.00 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL284737 | 1.00 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL20794222 | 1.00 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL10015774 | 1.00 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL896624 | 1.00 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL23396436 | 1.00 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL5962596 | 1.00 | AHCY (0.59) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL13986298 | 0.87 | AHCY (0.57) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL17833855 | 0.87 | AHCY (0.62) | AHCYADASTING1TP53CYP2C9 | |
| SCHEMBL13986311 | 0.87 | AHCY (0.57) | AHCYADASTING1TP53CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735592-A2 | THERAPEUTIC METHOD FOR MODULATING COMPARTMENTED CYCLIC ADENOSINE MONOPHOSPHATE IN REACTIVE ASTROCYTES | The Board of Trustees of the Leland Stanford Junior University (US) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025007065-A2 | THERAPEUTIC METHOD FOR MODULATING COMPARTMENTED CYCLIC ADENOSINE MONOPHOSPHATE IN REACTIVE ASTROCYTES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-01-02 | — | — | WO | disclosed |
| US-12180509-B2 | Methods for reprograming non-pluripotent cells into pluripotent stem cells | BEIHAO STEM CELL AND REGENERATIVE MEDICINE RESEARCH INSTITUTE CO., LTD. (CN) | 2024-12-31 | — | — | US | disclosed |
| EP-3384007-B1 | IMPROVED METHODS FOR REPROGRAMING NON-PLURIPOTENT CELLS INTO PLURIPOTENT STEM CELLS | BEIHAO STEM CELL AND REGENERATIVE MEDICINE RES INSTITUTE CO LTD (CN) | 2024-03-27 | — | — | EP | disclosed |
| CN-117157071-A | Compositions comprising autophagy activators as active ingredients for preventing or treating non-syndromic autosomal dominant deafness | 延世大学校产学协力团 | 2023-12-01 | — | — | CN | disclosed |
| CN-115885046-A | Inducible promoters for viral vector production | 阿斯克肋匹奥生物制药公司 | 2023-03-31 | — | — | CN | disclosed |
| US-11613552-B2 | Pharmaceutical agents, compositions, and methods relating thereto | ALLTECH, INC. (US) | 2023-03-28 | — | — | US | disclosed |
| WO-2022054927-A1 | COMPOSITION FOR AUTOPHAGY ACTIVATION | 国立大学法人大阪大学 | 2022-03-17 | — | — | WO | disclosed |
| WO-2022054926-A1 | AUTOPHAGY ACTIVATING COMPOSITION CONTAINING MORPHOLINE DERIVATIVE AS ACTIVE INGREDIENT | 国立大学法人大阪大学 | 2022-03-17 | — | — | WO | disclosed |
| US-20220025321-A1 | METHODS FOR REPROGRAMING NON-PLURIPOTENT CELLS INTO PLURIPOTENT STEM CELLS | HONG GUAN LTD. (CN) | 2022-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11613552-B2 | Pharmaceutical agents, compositions, and methods relating thereto | PCSK9, PCSK7, PDE3A | AHCY 2938/4885ADA 2058/4885STING1 4664/4885 |
| US-20220025321-A1 | METHODS FOR REPROGRAMING NON-PLURIPOTENT CELLS INTO PLURIPOTENT STEM CELLS | AHCY, BHMT, SHMT1 | AHCY 1/4885ADA 59/4885STING1 1455/4885 |
| US-12180509-B2 | Methods for reprograming non-pluripotent cells into pluripotent stem cells | AHCY, BHMT, SHMT1 | AHCY 1/4885ADA 59/4885STING1 1455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.